Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:57:03.512Z.
Calculation as of: 2026-10-06T14:57:03.512Z.
Quote observation: 2026-10-06T14:55:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea8f5c362e28cab1379660d94c14b865908cd29a247cab29e6d5b71901c6c862
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$775.12M
PE Ratio
N/A
TTM Avg
12.44
3Y Avg
5.97
5Y Avg
5.97
Market Cap
$763.47M
PE Ratio
162.42
TTM Avg
129.79
3Y Avg
309.15
5Y Avg
358.87
Market Cap
$798.26M
PE Ratio
N/A
TTM Avg
694.69
3Y Avg
438.87
5Y Avg
438.87
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $776.24M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | N/A | 12.44 | 5.97 | 5.97 |
| Mesa Laboratories, Inc. (MLAB)vs › | $763.47M | 162.42 | 129.79 | 309.15 | 358.87 |
| AdaptHealth Corp. (AHCO)vs › | $785.71M | N/A | 16.88 | 41.08 | 41.08 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $798.26M | N/A | 694.69 | 438.87 | 438.87 |
| Design Therapeutics, Inc. (DSGN)vs › | $755.11M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $760.77M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $753.58M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $804.16M | 11.37 | 9.51 | 9.54 | 15.29 |
| Apnimed, Inc. (APMD)vs › | $805.62M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$1.21
Forward EPS (Est.)
$-0.04
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2016-11-03 | 274.24 |
| 2016-11-02 | 280.30 |
| 2016-11-01 | 292.42 |
| 2016-10-31 | 280.30 |
| 2016-10-28 | 296.97 |
| 2016-10-27 | 304.55 |
| 2016-10-26 | 312.12 |
| 2016-10-25 | 313.64 |
| 2016-10-24 | 324.24 |
| 2016-10-21 | 321.21 |
| 2016-10-20 | 316.67 |
| 2016-10-19 | 315.15 |
| 2016-10-18 | 324.24 |
| 2016-10-17 | 315.15 |
| 2016-10-14 | 331.82 |
| 2016-10-13 | 334.85 |
| 2016-10-12 | 334.85 |
| 2016-10-11 | 357.58 |
| 2016-10-10 | 363.64 |
| 2016-10-07 | 346.97 |
| 2016-10-06 | 359.09 |
| 2016-10-05 | 346.97 |
| 2016-10-04 | 343.94 |
| 2016-10-03 | 346.97 |
| 2016-09-30 | 342.42 |
| 2016-09-29 | 333.33 |
| 2016-09-28 | 343.94 |
| 2016-09-27 | 342.42 |
| 2016-09-26 | 334.85 |
| 2016-09-23 | 333.33 |
| 2016-09-22 | 336.36 |
| 2016-09-21 | 340.91 |
| 2016-09-20 | 310.61 |
| 2016-09-19 | 303.03 |
| 2016-09-16 | 284.85 |
| 2016-09-15 | 298.48 |
| 2016-09-14 | 313.64 |
| 2016-09-13 | 328.79 |
| 2016-09-12 | 348.48 |
| 2016-09-09 | 433.33 |
| 2016-09-08 | 462.12 |
| 2016-09-07 | 462.12 |
| 2016-09-06 | 457.58 |
| 2016-09-02 | 416.67 |
| 2016-09-01 | 413.64 |
| 2016-08-31 | 407.58 |
| 2016-08-30 | 407.58 |
| 2016-08-29 | 403.03 |
| 2016-08-26 | 409.09 |
| 2016-08-25 | 404.55 |
| 2016-08-24 | 401.52 |
| 2016-08-23 | 413.64 |
| 2016-08-22 | 415.15 |
| 2016-08-19 | 412.12 |
| 2016-08-18 | 413.64 |
| 2016-08-17 | 413.64 |
| 2016-08-16 | 415.15 |
| 2016-08-15 | 434.85 |
| 2016-08-12 | 415.15 |
| 2016-08-11 | 409.09 |
| 2016-08-10 | 401.52 |
| 2016-08-09 | 413.64 |
| 2016-08-08 | 412.12 |
| 2016-08-05 | 418.18 |
| 2016-08-04 | 410.61 |
| 2016-08-03 | 1635.29 |
| 2016-08-02 | 1600.00 |
| 2016-08-01 | 1594.12 |
| 2016-07-29 | 1576.47 |
| 2016-07-28 | 1564.71 |
| 2016-07-27 | 1617.65 |
| 2016-07-26 | 1552.94 |
| 2016-07-25 | 1552.94 |
| 2016-07-22 | 1564.71 |
| 2016-07-21 | 1588.24 |
| 2016-07-20 | 1564.71 |
| 2016-07-19 | 1511.76 |
| 2016-07-18 | 1564.71 |
| 2016-07-15 | 1564.71 |
| 2016-07-14 | 1541.18 |
| 2016-07-13 | 1552.94 |
| 2016-07-12 | 1588.24 |
| 2016-07-11 | 1617.65 |
| 2016-07-08 | 1600.00 |
| 2016-07-07 | 1582.35 |
| 2016-07-06 | 1576.47 |
| 2016-07-05 | 1570.59 |
| 2016-07-01 | 1617.65 |
| 2016-06-30 | 1576.47 |
| 2016-06-29 | 1552.94 |
| 2016-06-28 | 1552.94 |
| 2016-06-27 | 1423.53 |
| 2016-06-24 | 1523.53 |
| 2016-06-23 | 1617.65 |
| 2016-06-22 | 1570.59 |
| 2016-06-21 | 1576.47 |
| 2016-06-20 | 1647.06 |
| 2016-06-17 | 1605.88 |
| 2016-06-16 | 1588.24 |
| 2016-06-15 | 1582.35 |
| 2016-06-14 | 1582.35 |
| 2016-06-13 | 1594.12 |
| 2016-06-10 | 1629.41 |
| 2016-06-09 | 1652.94 |
| 2016-06-08 | 1735.29 |
| 2016-06-07 | 1752.94 |
| 2016-06-06 | 1835.29 |
| 2016-06-03 | 1741.18 |
| 2016-06-02 | 1805.88 |
| 2016-06-01 | 1752.94 |
| 2016-05-31 | 1741.18 |
| 2016-05-27 | 1676.47 |
| 2016-05-26 | 1652.94 |
| 2016-05-25 | 1729.41 |
| 2016-05-24 | 1717.65 |
| 2016-05-23 | 1670.59 |
| 2016-05-20 | 1658.82 |
| 2016-05-19 | 1576.47 |
| 2016-05-18 | 1652.94 |
| 2016-05-17 | 1611.76 |
| 2016-05-16 | 1623.53 |
| 2016-05-13 | 1552.94 |
| 2016-05-12 | 1547.06 |
| 2016-05-11 | 1617.65 |
| 2016-05-10 | 1658.82 |
| 2016-05-09 | 1629.41 |
| 2016-05-06 | 1570.59 |
